INIS
diseases
100%
mice
86%
pancreas
79%
humans
77%
pediatrics
74%
patients
67%
genes
57%
antigens
51%
dendrites
51%
biological markers
50%
insulin
49%
tolerance
47%
liposomes
46%
cytokines
44%
blood
33%
immunotherapy
33%
lymphocytes
32%
inflammation
32%
monitoring
32%
molecules
26%
control
24%
receptors
23%
doses
23%
apoptosis
22%
expansion
22%
therapy
22%
reviews
22%
phagocytosis
21%
production
20%
spain
20%
peptides
19%
data
19%
levels
19%
macrophages
18%
in vitro
18%
diabetes mellitus
17%
information
16%
spleen
16%
tissues
16%
administration
16%
glucocorticoids
16%
standardization
16%
prediction
16%
errors
16%
maturation
15%
animals
14%
thymus
14%
drugs
14%
risks
14%
inhibition
14%
Immunology and Microbiology
Autoimmunity
59%
Nonobese Diabetic Mouse
52%
Immunotherapy
44%
Dendritic Cell
43%
Immune Tolerance
37%
Autoimmune Disease
37%
Cytokine
31%
Regulatory T Cell
29%
Autoantigen
29%
T Cell
28%
Mouse
25%
Antigen Specificity
25%
Immune Response
24%
Efferocytosis
21%
Immune System
20%
Autoimmune Diabetes
18%
Coeliac Disease
16%
Multiple Sclerosis
16%
B Cell
14%
Glucocorticoid
14%
Antigen Presentation
12%
Memory T Cell
12%
Maturation
12%
Gene Expression
11%
Thymus
10%
Diabetes Mellitus Type 1
10%
Pancreas
10%
Monocyte
10%
Antigen Presenting Cell
10%
Phagocytosis
10%
Fetus Lung Maturation
10%
Cell Expansion
10%
T Cell Receptor
8%
Interferon Type I
8%
Engraftment
8%
Sirolimus
8%
Natural Killer Cell
8%
Macrophage
8%
Cyclin D2
8%
Hematopoietic Stem Cell
8%
Tacrolimus
8%
Low Drug Dose
8%
Prostaglandin E2
8%
Inflammatory Arthritis
8%
Acute Graft Rejection
8%
HLA-DM
8%
Endocrine Cell
8%
Progeny
8%
Nervous System
8%
Pregnancy
8%
Keyphrases
Type 1 Diabetes Mellitus (T1DM)
24%
Type I Diabetes
24%
Partial Remission
24%
Pediatric Diabetes
24%
Human Pancreatic Islets
16%
Phosphatidylcholine Liposomes
16%
Liposomes
12%
Islet
12%
Spanish Government
12%
Non-obese Diabetic Mice
9%
Nanotherapeutics
9%
Dendritic Cells
9%
Tolerogenic Dendritic Cells
9%
NK Cell Subsets
9%
Hypoxia
8%
HLA-DM
8%
Tacrolimus
8%
Preclinical Evaluation
8%
Hyperexpression
8%
Diabetes
8%
Phagocytosis
8%
Lymphocyte Phenotype
8%
HIV-1 Restriction
8%
T Lymphocyte Subsets
8%
Male Mice
8%
Pediatric Type 1 Diabetes Mellitus
8%
Preterm Birth
8%
Cyclin D2 (CCND2)
8%
Endocrine Cells
8%
Diseases Therapeutic
8%
Sensory Stimuli
8%
System Elements
8%
Brain Injury
8%
Therapy Experiences
8%
Liberase
8%
Rapamycin
8%
European Regional Development Fund
8%
Usage Profile
8%
Perinatal Brain Injury
8%
REG Family Genes
8%
Human Inflammatory Bowel Disease
8%
Antigen-specific
8%
TAP1
8%
Macrophage Targeting
8%
Immune System Development
8%
Antenatal betamethasone
8%
Autoimmune Diabetes
8%
Betamethasone
8%
Petting
8%
Dipeptidyl Peptidase IV Inhibition
8%
